SEARCH RESULTS FOR: (*cryptocurrency meaning in bengali馃挷itenthusiasts.com馃挷Crypto*)(456341 results)
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
The VersaWrap wetting Solution is applied to the Sheet to render the Sheet a gelatinous, tissue adherent layer (gel in situ). The aqueous citrate Solution is provided sterile, non-pyrogenic, for single use, in a dropper, packaged in a double peel pouch.
Alafair Biosciences, Inc.
VSC-1
In Commercial Distribution
- B454VSC10 ()
VSC-1
- Nerve guide, synthetic polymer, bioabsorbable
- Tendon spacer
239SFM - DISPOSABLE device in titanium with nitride coating. Sphere of 1,8 mm; thread of 1,6 mm
239GSF - DISPOSABLE device in titanium. Threaded sleeve to be bonded with internal thread of 1,6 mm
239SSM - REUSABLE device in stainless steel. Spacer for modelization
RHEIN 83 SRL
THREADED MICRO SIZE SPHERE w/SLEEVE set
139KSFM
- Dental implant suprastructure, permanent, preformed
The CRoC is indicated for use in the battlefield to control difficult bleeds in the inguinal and axilla areas. The CRoC is also indicated for use in the battlefield as a last resort for life threatening bleeds of the carotid artery.
Safeguard US Operating, LLC
C
Not in Commercial Distribution
- M68931200C0 ()
31-200
- Emergency junctional haemorrhage compression set
Content: 20 ml For colouring the transparent areas in the interdental region Works well mixed with 50% Colour Liquid A1 Prettau in the incisal area Colour Liquid for Prettau® Zirconia for brush technique Use only in combination with metal-free brushes
ZIRKONZAHN SRL
FMAA5603
In Commercial Distribution
- D800FMAA5603 ()
- Dental articulation paste/solution
Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL syringe is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, e.g., acetaminophen. It is a viscous solution of purified natural Sodium Hylauronate (Hyalectin®) in buffered physiological sodium chloride. The sodium hylauronate is extracted from rooster combs. It is given by intra-articular injection in a treatment cycle consisting of five injections given at weekly intervals. Some patients may experience benefit with three injections given at weekly cycles. This has been noted in studies reported in the literature in which patients treated with three injections were followed for 60 days.
FIDIA FARMACEUTICI SPA
89122-0724-20
Not in Commercial Distribution
- M71389122072420A1 ()
89122-0724-20
- Synovial fluid supplementation medium
Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL vial is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, e.g., acetaminophen. It is a viscous solution of purified natural Sodium Hylauronate (Hyalectin®) in buffered physiological sodium chloride. The sodium hylauronate is extracted from rooster combs. It is given by intra-articular injection in a treatment cycle consisting of five injections given at weekly intervals. Some patients may experience benefit with three injections given at weekly cycles. This has been noted in studies reported in the literature in which patients treated with three injections were followed for 60 days.
FIDIA FARMACEUTICI SPA
89122-0724-12
In Commercial Distribution
- M71389122072412A1 ()
89122-0724-12
- Synovial fluid supplementation medium
Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL vial is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, e.g., acetaminophen. It is a viscous solution of purified natural Sodium Hylauronate (Hyalectin®) in buffered physiological sodium chloride. The sodium hylauronate is extracted from rooster combs. It is given by intra-articular injection in a treatment cycle consisting of five injections given at weekly intervals. Some patients may experience benefit with three injections given at weekly cycles. This has been noted in studies reported in the literature in which patients treated with three injections were followed for 60 days.
FIDIA FARMACEUTICI SPA
89122-0724-12
89122-0724-12
- Synovial fluid supplementation medium
2 - 1.10mm x 0.50cm VISICOIL separated by a 15mm PGLA spacer (Stranded with PGLA Sleeve) loaded in an 17 gauge pre-waxed brachytherapy needle 20cm in length.
Izi Medical Products, LLC
TLS-110-31517
In Commercial Distribution
- EIBATLS110315170 ()
TLS-110-31517
- Radiological image marker, implantable
2 - 0.75mm x 0.50cm VISICOIL separated by a 15mm PGLA Spacer (Stranded with PGLA Sleeve) loaded in an 18 gauge pre-waxed brachytherapy needle 20cm in length.
Izi Medical Products, LLC
TLS-075-31518
In Commercial Distribution
- EIBATLS075315180 ()
TLS-075-31518
- Radiological image marker, implantable
2 - 0.75mm x 0.50cm VISICOIL MR separated by 20mm PGLA spacer (Stranded with PGLA Sleeve) loaded in an 18 gauge pre-waxed brachytherapy needle 20cm in length.
Izi Medical Products, LLC
MRTLS-075-92018
In Commercial Distribution
- EIBAMRTLS075920180 ()
MRTLS-075-92018
- Radiological image marker, implantable